Abstract LB-203: Phase I/II study of the androgen receptor antagonist MDV3100 in castration-resistant prostate cancer
2021 ◽
Vol 64
(2)
◽
pp. 909-924
◽
2019 ◽
Vol 234
(9)
◽
pp. 15472-15486
◽
2017 ◽
Vol 80
(6)
◽
pp. 1063-1072
◽
2017 ◽
Vol 80
(6)
◽
pp. 1073-1077
◽
2019 ◽
Vol 171
◽
pp. 265-281
◽